e) Available statistics and research findings  on doping trends (e.g., anti -doping Testing  figures and anti -doping rule violation reports published by WADA ; peer -reviewed  articles);  f) Information received/intelligence developed on possible doping practices in the sport (e.g., Laboratory  and APMU  recommendations; Sample Collection Personnel  reports; Athlete testimony; information from criminal investigations; and/or other information received/intelligence developed in accordance with WADA’s  Guidelines for Information Gathering and Intelligence Sharing) in accordance with Article 11;  g) The outcomes of previous test distribution planning cycles including past Testing  strategies;  h) At what points during an Athlete’s  career in the sport/discipline an Athlete would be most likely to benefit from Prohibited Substances  and/or Prohibited Methods;  and i) Given the structure of the season for the sport/discipline in question (including standard Competition schedules and training patterns),  at what time(s) during the year/cycle an Athlete would be most likely to benefit from Prohibited Substances  and/or Prohibited Methods .